Pharmacists' performance of clinical interventions during adherence support medication reviews

Research in Social and Administrative Pharmacy

Volumn 10, Issue 1, 2014, Pages 185-194

  Hatah, Ernieda ^a,b   Tordoff, June ^a   Duffull, Stephen B ^a   Braund, Rhiannon ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Community pharmacy services; Drug utilization review; Medication therapy management; Pharmacists

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COUNSELING; DRUG USE; ECONOMICS; FEMALE; HEALTH LITERACY; HUMAN; MALE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; NEW ZEALAND; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; RETROSPECTIVE STUDY; STANDARD; VERY ELDERLY; YOUNG ADULT;

COMMUNITY PHARMACY SERVICES; DRUG UTILIZATION REVIEW; MEDICATION THERAPY MANAGEMENT; PHARMACISTS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; COUNSELING; FEMALE; HEALTH LITERACY; HUMANS; MALE; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; NEW ZEALAND; PHARMACISTS; PROFESSIONAL ROLE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84888884275     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2013.04.008     Document Type: Article

References (37)

1. Björkman I.K., Sanner M.A., Bernsten C.B. Comparing 4 classification systems for drug-related problems: Processes and functions. Res Soc Admin Pharm 2008, 4:320-331.
2. Cunningham G., Dodd T.R., Grant D.J., McMurdo M.E., Richards R.M. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997, 26:375-382.
3. Nelson K.M., Talbert R.L. Drug-related hospital admissions. Pharmacotherapy 1996, 16:701-707.
4. Cipolle R., Strand L., Morley P. Pharmaceutical Care Practice: The Patient Centered Approach to Medication Management 2012, McGraw-Hill companies, New York, 435. 3rd ed.
5. Royal Pharmaceutical Society. Medicines Use Review Audit Reports: Annual Report 2009/10. Available at: Accessed 25.11.12. http://www.qi4pd.org.uk/images/stories/MUR%20Audit%20Reports/MUR%20Pharmacy%20audit%20data%20July%2009%20to%20Dec%2009.pdf.
6. Portlock J., Holden M., Patel S. A community pharmacy asthma MUR project in Hampshire and the Isle of Wight. Pharm J 2009, 282:109-112.
7. Brandt T., Harrison J., Sheridan J., Shaw J., Jensen M. The Evaluation of Auckland District Health Board's Medicines Use Review Pilot: The ADMiRE Report 2009, Available at:, Accessed 19.11.12. http://www.adhb.govt.nz/PHO/documents/ADMiRE%20report%20final.pdf.
8. Price A. Pharmaceutical care award 2009: effectiveness of medicines use reviews in asthma. Pharm J 2009, 283:11.
9. Baglole L.E., Beaumont A., Morgan I. Outcomes of medicines use reviews for people with asthma. Int J Pharm Pract 2007, 15(Supp/2):B66.
10. Ellis S.L., Carter B.L., Malone D.C., et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000, 20:1508-1516.
11. Fox D., Ried L.D., Klein G.E., Myers W., Foli K. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. JAm Pharm Assoc 2009, 49:192-199.
12. Isetts B.J., Schondelmeyer S.W., Artz M.B., Lenarz L.A. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc 2008, 48:203-211.
13. Planas L.G., Crosby K.M., Mitchell K.D., Farmer K.C. Evaluation of a hypertension medication therapy management program in patients with diabetes. JAm Pharm Assoc 2009, 49:164-170.
14. Taylor C.T., Byrd D.C., Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 2003, 60(11):1123-1129.
15. Ramalho de Oliveira D., Brummel A.R., Miller D.B. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm 2010, 16:185-195.
16. Clyne W., Blenkinsopp A., Seal R. A Guide to Medication Review 2008, Available at:, Accessed 24.10.12. http://www.npc.nhs.uk/review_medicines/intro/resources/agtmr_web1.pdf.
17. Medicines management: definition, levels, competence framework 2006, Pharmacy Council of New Zealand, Available at:, Accessed 14.08.11. http://www.pharmacycouncil.org.nz/cms_show_download.php?id=124.
18. New Zealand National Pharmacist Services Framework 2007, District Health Board Shared Services, Available at:, Accessed 13.09.12. http://www.dhbsharedservices.health.nz/Site/SIG/NPSF/NPSF-Framework.aspx.
19. Lee E., Braund R., Tordoff J. Examining the first year of medicines use review services provided by pharmacist in New Zealand 2008. N Z Med J 2009, 122(1293):26-35.
20. Lynne MB. Medication management: New Zealand. In: Weitz M and Naglieri C, eds. Pharmaceutical Care Practice: The Patient Centered Approach to Medication Management. The McGraw-Hill Companies, New York, USA. 461-477.
21. Medication Therapy Management in Pharmacy Practice: Core Elements of an MTM service Model 2008, American Pharmacists Association and National Association of Chain Drug Stores Foundation, Available at:, Accessed 05.11.12. http://www.pharmacist.com/sites/default/files/files/core_elements_of_an_mtm_practice.pdf.
22. Australia Government, Department of Human Services. Home Medicines Review (HMR). Available at: Accessed 10.02.13. http://www.medicareaustralia.gov.au/provider/pbs/fourth-agreement/hmr.jsp.
23. Zermansky A., Petty D.R., Raynor D.K., Freemantle N., Vail A., Lowe C.J. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001, 323(7325):1340.
24. Celino G., Gray N., Blenkinsopp A., Bond C., Inch J. General practitioners' experiences of medicines use review: qualitative from the national evaluation of the community pharmacy contractual framework in England and Wales. Int J Pharm Pract 2007, 15(Suppl. 2):B20-B21.
25. Devon and Gloucestershire Local Pharmaceutical Committees. Medicines Use Review (MUR): source pack for community pharmacies 2007. Available at:. Accessed 04.12.12. http://www.lpc-online.org.uk/bkpage/files/192/microsoft_word__mur_resources__4_.pdf.
26. Stafford A.C., Tenni P.C., Peterson G.M., et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci 2009, 31:216-223.
27. Welch E.K., Delate T., Chester E.A., Stubbings T. Assessment of the impact of Medication Therapy Management delivered to home-based Medicare beneficiaries. Ann Pharmacother 2009, 43:603-610.
28. Roughead E.E., Barratt J.D., Gilbert A.L. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 2004, 13:83-87.
29. Doucette W.R., McDonough R.P., Klepser D., McCarthy R. Comprehensive Medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 2005, 27:1104-1111.
30. Pharmaceutical Care Network Europe Foundation. The PCNE classification for drug-related problems V6.2. Available at: Accessed 04.04.12. http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V6-2.pdf.
31. PCNE Guidelines for Retrospective Medication Review Pharmacy V0 2011, Pharmaceutical Care Network Europe, Available at:, Accessed 02.12.12. http://www.pcne.org/sig/MedRev/documents/PCNE%20Guidelines%20MR%20V0.pdf.
32. Roughead E. The nature and extent of drug-related hospitalizations in Australia. J Qual Clin Prac 2002, 19:19-22.
33. van Mil J.W., Westerlund L.O., Hersberger K.E., Schaefer M.A. Drug-related problem classification systems. Ann Pharmacother 2004, 38(5):859-867.
34. Pharmacy Council of New Zealand. Safe Effective Pharmacy Practice: Code of Ethics 2011. Available at: Accessed 13.09.12. http://www.pharmacycouncil.org.nz/cms_show_download.php?id=200.
35. Armstrong E.P. Community pharmacists' opinions about having diagnostic data provided with prescriptions. J Pharm Pract 2003, 16(5):361.
36. Avery T, Barber N, Ghaleb M, et al. Investigating the prevalence and causes of prescribing errors in general practice: the PRACtICe study. 2012. Available at: Accessed 02.12.12. http://www.gmc-uk.org/Investigating_the_prevalence_and_causes_of_prescribing_errors_in_general_practice___The_PRACtICe_study_Reoprt_May_2012_48605085.pdf.
37. Wells KM, Boardman HF, Thornely T. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service prior to implementation. Res Soc Admin Pharm. in press.